Pain O Soma (Carisoprodol): Uses, Dosage, Side Effects & Complete Guide (2026)
- Dr. Tobias Kohler

- Aug 2
- 7 min read
If you have ever been prescribed a muscle relaxant for back pain, a neck injury, or muscle spasm — or searched for a more affordable alternative to brand-name Soma — you have probably come across Pain O Soma. It is one of the most widely used generic names for Carisoprodol, a centrally-acting skeletal muscle relaxant that has been FDA-approved since 1959 and remains one of the most commonly prescribed medicines for acute musculoskeletal pain in the United States.
This complete guide covers exactly what Pain O Soma is, how it works, the difference between the 350mg and 500mg strengths, correct dosage and administration, side effects, safety warnings, important drug interactions, and how to buy pharmaceutical-grade Pain O Soma at the most affordable price in the USA.
At TheMedicineKart, we stock Pain O Soma (Carisoprodol 500mg) sourced from WHO-GMP certified manufacturers, with USA-to-USA delivery in 4 business days and 50% off your first order using code MK50. Browse at www.themedicinekart.com/pain-management

What Is Pain O Soma?
Pain O Soma is a brand name of pharmaceutical-grade generic Carisoprodol manufactured by HAB Pharmaceuticals, one of India's WHO-GMP certified pharmaceutical manufacturers. It contains the same active ingredient — Carisoprodol — as the American brand-name Soma, manufactured by Meda Pharmaceuticals.
A real-world example of the brand vs generic comparison:
Product | Active Ingredient | Manufacturer | Typical USA Retail Price |
Soma (brand) | Carisoprodol 350mg | Meda Pharmaceuticals | ~$35–$60 per pack |
Pain O Soma (generic) | Carisoprodol 500mg | HAB Pharmaceuticals (WHO-GMP) | As low as $0.80–$1.50/tablet at TheMedicineKart |
The active ingredient is the same. The mechanism of action is the same. The price difference — like all generic vs branded medicine differences — comes entirely from development and patent costs, not from quality.
How Does Carisoprodol Work?
Carisoprodol is classified as a centrally-acting skeletal muscle relaxant. The precise mechanism is not fully understood, but research indicates it works primarily through the central nervous system (CNS) rather than directly on skeletal muscle fibres.
Carisoprodol alters interneuronal activity in the spinal cord and in the descending reticular formation of the brain — effectively reducing the transmission of pain signals between nerves and the brain. It does not directly relax the muscle tissue itself; instead, it interrupts the nerve pain cycle that is causing the muscle to spasm and tighten.
An important pharmacological note: Carisoprodol is metabolised in the liver to its primary metabolite, meprobamate — which is itself a tranquiliser-class compound (related to benzodiazepines). This meprobamate metabolite contributes meaningfully to the drug's sedative effect and is also responsible for its abuse potential and the requirement for Schedule IV controlled substance classification in the USA.
Strength | FDA-Approved Dose Range | Typical Use | Notes |
350mg | 250–350mg, 3 times daily + at bedtime | Standard starting dose; milder spasm | Brand-name Soma comes in 250mg and 350mg |
500mg | Off-label in USA; used internationally | More severe acute spasm; widely used globally | Pain O Soma 500mg is the most common international formulation |
The FDA-approved dosage range for Carisoprodol in the USA is 250mg to 350mg three times a day and at bedtime — a maximum of four doses per 24 hours. The 500mg tablet available as Pain O Soma is a higher-strength formulation that is widely used internationally but sits above the standard FDA-approved per-dose range. Always follow the dose prescribed by your physician — do not self-adjust to the 500mg strength without medical guidance.
Dosage and Administration
Standard adult dosage (per FDA prescribing information):
250mg to 350mg, three times daily and at bedtime
Maximum daily dose: four doses (three daytime + one bedtime)
Maximum duration: 2 to 3 weeks
Not approved for use in anyone under 16 years of age
Not intended for long-term or chronic pain use — Carisoprodol is specifically labelled for short-term acute musculoskeletal conditions only
How to take Pain O Soma:
Take with or without food — food does not significantly affect absorption
Take with a full glass of water
If you miss a dose, take it as soon as you remember — but skip if it is close to the time of your next dose. Never double-dose.
Do not crush or chew tablets — swallow whole
Always use Carisoprodol alongside:
Rest — the medicine treats discomfort while the underlying injury heals; it does not accelerate tissue repair
Physical therapy — recommended by most prescribing guidelines as a concurrent treatment
Avoidance of activities requiring alertness, such as driving or operating heavy machinery, particularly in the first days of use.
What Is Pain O Soma Used For?
Carisoprodol is FDA-approved for short-term relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Common conditions for which it is prescribed include:
Acute lower back pain and muscle spasm
Neck pain and cervical muscle spasm
Muscle injuries from sports, accidents, or sudden strain
Post-surgical muscle pain where short-term muscle relaxation is indicated
Fibromyalgia flares (off-label, short-term use)
Whiplash-associated muscle spasm
Carisoprodol is not appropriate for chronic pain conditions, neurological spasticity (such as spasticity from multiple sclerosis), or long-term pain management. For these indications, different medication classes are recommended.
Pain O Soma Side Effects
Common side effects (reported in clinical studies):
Drowsiness — the most commonly reported effect, present in a significant proportion of users
Dizziness and light-headedness
Headache
Nausea
Flushing (feeling of warmth or redness)
Less common but important:
Tachycardia (rapid heart rate)
Postural hypotension (blood pressure drop when standing up)
Tremor
Irritability or mood changes
Difficulty with coordination
Serious — seek immediate medical attention:
Severe allergic reaction — hives, swelling of face or throat, difficulty breathing
Seizures — particularly in patients with a history of seizure disorders
Extreme CNS depression — difficulty staying awake, confusion, slowed breathing
Signs of meprobamate toxicity in overdose — low blood pressure, rapid heart rate, coma
Important Safety Warnings
Controlled substance
Schedule IV (USA): Carisoprodol is classified as a Schedule IV controlled substance by the DEA, meaning it has recognised potential for abuse and dependence. This is primarily due to its meprobamate metabolite, which has sedative and reinforcing properties. Risk is highest in patients with a history of substance use disorder.
Short-term use only:
Carisoprodol is specifically approved only for acute, short-term use of up to 2–3 weeks. The prescribing information notes that most musculoskeletal injuries are of short duration and that there is no adequate evidence of effectiveness for longer-term use — while the risks of dependence and tolerance increase significantly with prolonged use.
Do not use if you have:
Porphyria — a genetic enzyme disorder affecting the skin or nervous system; Carisoprodol is contraindicated
A known allergy to Carisoprodol or meprobamate
A history of substance use disorder — use with great caution and physician oversight only
Do not use during pregnancy or breastfeeding: It is not known whether Carisoprodol harms an unborn baby. Carisoprodol does pass into breast milk and may cause drowsiness in a nursing infant. Always inform your doctor if you are pregnant or breastfeeding before taking this medicine.
Older adults: People over 65 may be more sensitive to the CNS effects of Carisoprodol. Some prescribing guidelines caution against routine use in elderly patients due to increased fall risk from sedation and dizziness.
Drug / Substance | Interaction Risk | What Happens |
Alcohol | High | Additive CNS depression — dangerous sedation, respiratory depression |
Benzodiazepines (e.g. diazepam, alprazolam) | High | Additive CNS and respiratory depression |
Opioid pain medicines | High | Enhanced sedation and respiratory depression — FDA black box risk |
Other CNS depressants (sedatives, sleep aids) | Moderate–High | Additive drowsiness and CNS depression |
CYP2C19 inhibitors (e.g. omeprazole, fluconazole) | Moderate | Increased Carisoprodol plasma levels — more sedation |
Tramadol | Moderate | Additive CNS depression; also lowers seizure threshold |
Never combine Carisoprodol with alcohol, benzodiazepines, or opioids without explicit medical supervision. This combination is associated with a significantly elevated risk of CNS and respiratory depression serious enough to require emergency care.
Drug | Mechanism | Duration of Action | Controlled? | Best For |
Carisoprodol (Pain O Soma) | CNS — meprobamate pathway | 4–6 hours | Yes — Schedule IV | Acute short-term muscle spasm |
Cyclobenzaprine (Flexeril) | CNS — tricyclic-related | 12–24 hours | No | Acute back/neck spasm |
Methocarbamol (Robaxin) | CNS — mechanism unclear | 4–6 hours | No | Acute muscle spasm, less sedating |
Tizanidine (Zanaflex) | Alpha-2 agonist | 3–6 hours | No | Spasticity (MS, spinal injury) |
Baclofen | GABA-B agonist | 4–8 hours | No | Spasticity — not acute spasm |
Carisoprodol is generally reserved for acute, short-duration musculoskeletal conditions where other options have not provided sufficient relief. Its controlled substance status and abuse potential make it less suitable as a first-line agent for all patients compared to non-controlled alternatives like cyclobenzaprine or methocarbamol.
Where to Buy Pain O Soma (Carisoprodol) in the USA
TheMedicineKart stocks Pain O Soma 500mg (Carisoprodol), manufactured by HAB Pharmaceuticals — a WHO-GMP certified Indian pharmaceutical manufacturer supplying regulated markets globally.
Sourced from WHO-GMP certified manufacturers
Pharmaceutical-grade — identical active ingredient to brand-name Soma
USA-to-USA delivery in 4 business days in discreet plain packaging
50% off first order with code MK50
Free shipping on orders above $199
Browse Pain O Soma and our full Pain Management range at www.themedicinekart.com/pain-management
Frequently Asked Questions
What is Pain O Soma used for?
Pain O Soma (Carisoprodol) is a centrally-acting skeletal muscle relaxant used for the short-term relief of discomfort associated with acute, painful musculoskeletal conditions — such as back pain, muscle spasm from injury, neck pain, and muscle strain. It is always used alongside rest and physical therapy, not as a standalone treatment. It is only approved for short-term use of up to 2–3 weeks.
What is the difference between Pain O Soma 350mg and 500mg?
350mg corresponds to the standard FDA-approved per-dose range for Carisoprodol in the USA (250–350mg, up to four times daily). 500mg is a higher-strength formulation widely used internationally that exceeds the standard FDA-approved per-dose amount. Always follow the strength and dose prescribed by your doctor. Do not switch strengths without medical guidance.
Is Pain O Soma the same as Soma?
Yes — both contain Carisoprodol as their active ingredient. Pain O Soma is a pharmaceutical-grade generic manufactured by HAB Pharmaceuticals (WHO-GMP certified). Soma is the brand-name version manufactured by Meda Pharmaceuticals. The active ingredient, mechanism, and therapeutic effect are the same; the price is significantly lower for the generic.
Can Pain O Soma cause dependence?
Yes. Carisoprodol is a Schedule IV controlled substance in the USA precisely because it carries a recognised risk of abuse, dependence, and withdrawal — particularly with prolonged use. The risk is higher in patients with a personal or family history of substance use disorder. This is one of the core reasons it is approved only for short-term use of up to 2–3 weeks.
Can I take Pain O Soma with ibuprofen or paracetamol?
Carisoprodol is commonly prescribed alongside NSAIDs such as ibuprofen or naproxen for combined muscle relaxation and anti-inflammatory effect — many doctors consider this combination appropriate for acute musculoskeletal pain. Combining with paracetamol is also generally considered safe in standard doses. However, always confirm any combination with your prescribing physician, and never combine Carisoprodol with alcohol, opioids, or benzodiazepines without explicit medical supervision.




Comments